BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33632283)

  • 21. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
    Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
    Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased live births in women with systemic lupus erythematosus.
    Vinet E; Clarke AE; Gordon C; Urowitz MB; Hanly JG; Pineau CA; Isenberg D; Rahman A; Wallace D; Alarcón GS; Bruce I; Petri M; Dooley MA; Kalunian K; Maddison P; Aranow C; van Vollenhoven R; Bernatsky S
    Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1068-72. PubMed ID: 21425248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
    Choi MY; Chen I; Clarke AE; Fritzler MJ; Buhler KA; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Sontag D; Costenbader KH
    Ann Rheum Dis; 2023 Jul; 82(7):927-936. PubMed ID: 37085289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center.
    Artim-Esen B; Çene E; Şahinkaya Y; Ertan S; Pehlivan Ö; Kamali S; Gül A; Öcal L; Aral O; Inanç M
    J Rheumatol; 2014 Jul; 41(7):1304-10. PubMed ID: 24833757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
    Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
    J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of Thyroid Autoantibodies,System Lupus Erythematosus Immunologic Indicators and Disease Activity in SLE with HT].
    Liu H; Yang LH; Yin G; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):179-182. PubMed ID: 29737056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases.
    Aragón CC; Posso-Osorio I; Puerta G; González JD; Naranjo JC; Echeverri A; Ortíz E; Nieto-Aristizábal I; Barrera MC; Ríos-Serna LJ; Tobón GJ
    Clin Rheumatol; 2020 Jul; 39(7):2163-2169. PubMed ID: 32086623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile.
    Lindelöf L; Rantapää-Dahlqvist S; Lundtoft C; Sandling JK; Leonard D; Sayadi A; Rönnblom L; Enocsson H; Sjöwall C; Jönsen A; Bengtsson AA; Hong MG; Diaz-Gallo LM; Bianchi M; Kozyrev SV; Lindblad-Toh K; ; ; Nilsson Ekdahl K; Nilsson B; Gunnarsson I; Svenungsson E; Eriksson O
    J Autoimmun; 2024 Feb; 143():103166. PubMed ID: 38219652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus.
    Posselt RT; Coelho VN; Skare TL
    Int J Rheum Dis; 2018 Jan; 21(1):186-193. PubMed ID: 28544477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study.
    Chevet B; Figueroa-Parra G; Yang JX; Hocaoglu M; Osei-Onomah SA; Hulshizer CA; Gunderson TM; Cornec D; Barbour KE; Greenlund KJ; Crowson CS; Duarte-García A
    Arthritis Res Ther; 2022 Sep; 24(1):211. PubMed ID: 36050780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
    Chung SA; Nititham J; Elboudwarej E; Quach HL; Taylor KE; Barcellos LF; Criswell LA
    PLoS One; 2015; 10(7):e0129813. PubMed ID: 26192630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.